RE:RE:RE:Time to Market for H2S PipelineYou're making a huge assumption re H2S's effect on the liver. The supposed toxicity you;'re alluding to is elevated LTEs, which is a class issue with NSAIDs and indeed ALL other medications on a longer time horizon. So H2S is not at play here.
In fact H2S has been shown to protect the liver through various mechanisms such as:
-fatty acid oxidation
-mitochondrial bioenrgetics in the heptocytes
-improvment in glucose metabloism through the electron transport chain
the list goes on.
This sell off is because of lack of upcoming catalysts, delays, and no fixed timeframes for the new indication the company is taking. In simple terms, the issue is with the management, not the science.
Biotech ROI can be decades in many cases. People should be aware of that to adjust their risk tolerance and opportunity cost accordingly.
I would be weary of the intentions and intelleginece of posters who use hyperbolic statements like "worthless", "last nail in the coffin", "people got f*cked up", especially when making monetary decisions.
Layth1990 wrote: Be realistic. If H2S is toxic , then all the platform is worthless . Do not give false hopes to anyone. People got f*cked up here, leave them alone.